Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Iterum Therapeutics plc - Ordinary Share (NQ:ITRM)

0.9652 -0.0094 (-0.96%)
Streaming Delayed Price Updated: 3:14 PM EDT, Jul 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Iterum Therapeutics plc - Ordinary Share

< Previous 1 2 3 4 5 Next >
Earnings Scheduled For May 13, 2025
Via Benzinga
A Look Ahead: Iterum Therapeutics's Earnings Forecast
Via Benzinga
Top movers in Tuesday's pre-market session
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For February 7, 2025
Via Benzinga
A Look at Iterum Therapeutics's Upcoming Earnings Report
Via Benzinga
Iterum Therapeutics's Earnings: A Preview
Via Benzinga
Recap: Iterum Therapeutics Q3 Earnings
Via Benzinga
Wall Street Drops On Tariffs Threat, Dollar Rises, Uber Rockets On Ackman's Tweet: What's Driving Markets Friday?
Wall Street slumped into negative territory late in the week as renewed fears over inflation and trade tariffs eroded risk appetite. 
Via Benzinga
Topics Economy World Trade
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Earnings Outlook For Iterum Therapeutics
Via Benzinga
Iterum Therapeutics's Earnings: A Preview
Via Benzinga
Earnings Scheduled For November 14, 2024
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
FDA Approval Of Orlynvah For Urinary Tract Infections Marks Milestone For Iterum, Paves Way For New Strategic Partnerships
Iterum Therapeutics' Orlynvah receives FDA approval for treating uncomplicated UTIs in adult women, marking its first approved indication and a U.S. first for oral penems. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q2 2024
ITRM stock results show that Iterum Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q1 2024
ITRM stock results show that Iterum Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start the trading week with a dive into the biggest pre-market stock movers worth watching on Monday morning! 
Via InvestorPlace
ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q4 2023
ITRM stock results show that Iterum Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 28, 2024
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why Iterum Therapeutics Stock Is Trending Today
Iterum Therapeutics announced positive topline results from its REASSURE (REnewed ASsessment of Sulopenem in uUTI caused by Resistant Enterobacterales) Phase 3 clinical trial comparing oral sulopenem... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Insiders Buying Iterum Therapeutics And 3 Other Stocks Under $3
The Dow Jones index closed higher by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Earnings Scheduled For August 11, 2023
Companies Reporting Before The Bell • Consolidated Water Co (NASDAQ:CWCO) is estimated to report quarterly earnings at $0.22 per share on revenue of $30.27 million. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.